These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37678556)

  • 1. Randomized, double-blind, controlled trial of a combination of alpha-lipoic acid and pregabalin for neuropathic pain: the PAIN-CARE trial.
    Gilron I; Robb S; Tu D; Holden RR; Jackson AC; Duggan S; Milev R
    Pain; 2024 Feb; 165(2):461-469. PubMed ID: 37678556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination analgesic development for enhanced clinical efficacy (the CADENCE trial): a double-blind, controlled trial of an alpha-lipoic acid-pregabalin combination for fibromyalgia pain.
    Gilron I; Robb S; Tu D; Holden RR; Milev R; Towheed T
    Pain; 2023 Aug; 164(8):1783-1792. PubMed ID: 36877492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregabalin for neuropathic pain in adults.
    Derry S; Bell RF; Straube S; Wiffen PJ; Aldington D; Moore RA
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD007076. PubMed ID: 30673120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination Analgesic Development for Enhanced Clinical Efficacy (CADENCE Trial): Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of an Alpha-Lipoic Acid - Pregabalin Combination for the Treatment of Fibromyalgia Pain.
    Gilron I; Tu D; Holden R; Towheed T; Vandenkerkhof E; Milev R
    JMIR Res Protoc; 2017 Aug; 6(8):e154. PubMed ID: 28778847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
    Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.
    Zin CS; Nissen LM; O'Callaghan JP; Duffull SB; Smith MT; Moore BJ
    J Pain; 2010 May; 11(5):462-71. PubMed ID: 19962354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study.
    Tölle T; Freynhagen R; Versavel M; Trostmann U; Young JP
    Eur J Pain; 2008 Feb; 12(2):203-13. PubMed ID: 17631400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination pharmacotherapy for the treatment of neuropathic pain in adults.
    Chaparro LE; Wiffen PJ; Moore RA; Gilron I
    Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD008943. PubMed ID: 22786518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial.
    Lesser H; Sharma U; LaMoreaux L; Poole RM
    Neurology; 2004 Dec; 63(11):2104-10. PubMed ID: 15596757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pain Improvement With Novel Combination Analgesic Regimens (PAIN-CARE): Randomized Controlled Trial Protocol.
    Gilron I; Tu D; Holden R; Jackson AC; Ghasemlou N; Duggan S; Vandenkerkhof E; Milev R
    JMIR Res Protoc; 2017 Jun; 6(6):e111. PubMed ID: 28596150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of pregabalin on pain-related sleep interference in diabetic peripheral neuropathy or postherpetic neuralgia: a review of nine clinical trials.
    Roth T; van Seventer R; Murphy TK
    Curr Med Res Opin; 2010 Oct; 26(10):2411-9. PubMed ID: 20812792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregabalin for Neuropathic Pain: Why Benefits Could Be Expected for Multiple Pain Conditions.
    Ogawa S; Arakawa A; Hayakawa K; Yoshiyama T
    Clin Drug Investig; 2016 Nov; 36(11):877-888. PubMed ID: 27448285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study).
    Ziegler D; Hanefeld M; Ruhnau KJ; Meissner HP; Lobisch M; Schütte K; Gries FA
    Diabetologia; 1995 Dec; 38(12):1425-33. PubMed ID: 8786016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregabalin in patients with inadequately treated painful diabetic peripheral neuropathy: a randomized withdrawal trial.
    Raskin P; Huffman C; Toth C; Asmus MJ; Messig M; Sanchez RJ; Pauer L
    Clin J Pain; 2014 May; 30(5):379-90. PubMed ID: 23887339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregabalin for acute and chronic pain in adults.
    Moore RA; Straube S; Wiffen PJ; Derry S; McQuay HJ
    Cochrane Database Syst Rev; 2009 Jul; (3):CD007076. PubMed ID: 19588419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial.
    Tesfaye S; Sloan G; Petrie J; White D; Bradburn M; Julious S; Rajbhandari S; Sharma S; Rayman G; Gouni R; Alam U; Cooper C; Loban A; Sutherland K; Glover R; Waterhouse S; Turton E; Horspool M; Gandhi R; Maguire D; Jude EB; Ahmed SH; Vas P; Hariman C; McDougall C; Devers M; Tsatlidis V; Johnson M; Rice ASC; Bouhassira D; Bennett DL; Selvarajah D;
    Lancet; 2022 Aug; 400(10353):680-690. PubMed ID: 36007534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregabalin for peripheral neuropathic pain: a multicenter, enriched enrollment randomized withdrawal placebo-controlled trial.
    Gilron I; Wajsbrot D; Therrien F; Lemay J
    Clin J Pain; 2011; 27(3):185-93. PubMed ID: 21178603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double-blind, placebo-controlled trial.
    Satoh J; Yagihashi S; Baba M; Suzuki M; Arakawa A; Yoshiyama T; Shoji S
    Diabet Med; 2011 Jan; 28(1):109-16. PubMed ID: 21166852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial.
    Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
    Clin Drug Investig; 2009; 29(4):231-41. PubMed ID: 19301937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.